What is Bacterial Meningitis Market?
Meningitis and encephalitis are important causes of admissions and mortality for children in Zambia. Bacterial meningitis is the most serious type of meningitis that can lead to death or permanent disability. It affects the meninges, the membranes that surround the brain and spinal cord and protects the central nervous system (CNS), together with the cerebrospinal fluid. In bacterial meningitis, approximately 80 percent of all cases are acute bacterial meningitis. It can be life-threatening because it affects the tissues around the brain to swell. This can result in paralysis or stroke.
The market study is being classified by Type (Pneumococcal meningitis, Meningococcal meningitis, Listeria monocytogenes meningitis, Neonatal meningitis and Hemophilus (Hib) meningitis) and major geographies with country level break-up.
B. Braun (Germany), Sanofi S.A. (France), Pfizer Inc. (United States), Siemens Healthineers AG (Germany), GlaxoSmithKline Plc (United Kingdom), Merck Group (Germany), Baxter International Inc. (United States), Abbott Laboratories (United States), Bio-Rad Laboratories, Inc. (United States) and Thermo Fisher Scientific Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Luminex Corporation (United States), Roche Holding AG (Switzerland) and Cepheid (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Bacterial Meningitis market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Bacterial Meningitis market by Type, Application and Region.
On the basis of geography, the market of Bacterial Meningitis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Bacterial Meningitis in Regions such as Zambia
- Increasing Number of Diagnostic Centres
- RIse in the Healthcare Infrastructure in Developing Regions
- Huge Investments by the Major Players
- Side Effects of the Medicines
- Growth in the Healthcare Industry
- Increasing Research and Development Activities
- Increasing Demand for Effective Treatment
- Stringent Government Rules and Regulations
Market Leaders and some development strategies
In July 2018, B. Braun Medical Inc. (B. Braun), a market leader in renal therapies, infusion therapy, and pain management, has signed an agreement to acquire the bloodlines business operated under the Medisystems name by NxStage Medical, Inc., a medical technology company based in Lawrence, Massachusetts (NxStage).
In February 2018, GSK’s meningitis B vaccine Bexsero receives Breakthrough Therapy Designation from US FDA for the prevention of Invasive Meningococcal Disease in children 2-10 years of age.
Key Target AudienceBacterial Meningitis Treatment Providers, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase